The trend of increasing circulating levels of inflammatory markers (TNF-α, CRP and IL-1β) and NLRP3 levels with respect to increasing MetS components in the three study groups in females is depicted in Figure 1. The gene discussed is NLRP3; the disease is metabolic syndrome.